These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2764534)

  • 1. Dose-dependent pharmacokinetics of mezlocillin in rats.
    Jungbluth GL; Jusko WJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):839-43. PubMed ID: 2764534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
    Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
    Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment.
    Mangione A; Boudinot FD; Schultz RM; Jusko WJ
    Antimicrob Agents Chemother; 1982 Mar; 21(3):428-35. PubMed ID: 6213190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental pharmacokinetics of mezlocillin in 4 newborn infants.
    Jungbluth GL; Wirth FH; Rubio TT; Janicke DM; Jusko WJ
    Dev Pharmacol Ther; 1988; 11(6):317-21. PubMed ID: 3229277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
    Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
    Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of mezlocillin disposition with a porcine model.
    DiPiro JT; Davis JB; Boudinot FD; Cheung RP; Sisley JF
    Biopharm Drug Dispos; 1989; 10(6):563-72. PubMed ID: 2611357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental pharmacokinetics of mezlocillin in newborn infants.
    Janicke DM; Rubio TT; Wirth FH; Karotkin EH; Jusko WJ
    J Pediatr; 1984 May; 104(5):773-81. PubMed ID: 6716226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of two multiple-dose mezlocillin regimens.
    Janicke DM; Parker SW; Cafarell RF; Apicella MA; Jusko WJ
    Antimicrob Agents Chemother; 1988 May; 32(5):777-9. PubMed ID: 3395106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of continuous mechanical hemofiltration on the pharmacokinetics of antibiotics exemplified by mezlocillin].
    Boldt J; Salomon F; Krumholz W; Hempelmann G
    Anasth Intensivther Notfallmed; 1988 Apr; 23(2):91-4. PubMed ID: 3394906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mezlocillin pharmacokinetics in pediatric oncology patients.
    Kramer WG; Pickering LK; Culbert S; Frankel LS
    Antimicrob Agents Chemother; 1984 Jan; 25(1):62-4. PubMed ID: 6703685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of mezlocillin in healthy volunteers.
    Bergan T
    Antimicrob Agents Chemother; 1978 Dec; 14(6):801-6. PubMed ID: 742869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.